NCATS Archives

Dec 10

0

NGLY1.org Research update: Generation of an induced pluripotent stem cell line …

By admin | Research and Science, Researchers and Clinicians | No Comments

NGLY1.org is thrilled to be actively involved in this important research! Generation of an induced pluripotent stem cell line (TRNDi002-B) from a patient carrying compound heterozygous p.Q208X and p.G310G mutations…

Oct 03

0

Job Opportunity: Postdoc for Innovative NGLY1 Project

By NGLY1.org | Research and Science | No Comments

BIOLOGY OF RARE AND NEGLECTED DISEASES NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES, BETHESDA, MD AND SURROUNDING AREA Position Description: The biology group in the Therapeutics for Rare and Neglected Disease…

Sep 05

1

Exciting News! CRADA with Retrophin, NCATS and NGLY1.org

By NGLY1.org | Media, NGLY1 Deficiency, NGLY1.org, Research and Science | No Comments

SAN DIEGO, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ:RTRX) today announced that it has entered into a three-way Cooperative Research and Development Agreement (CRADA) with the National Institutes...

Jul 12

0

NCATS Advocacy Day 2017

By NGLY1.org | Events, NGLY1.org, Rare Disease | No Comments

Carrie Ostrea, NGLY1.org's Executive Director, participated in the inaugural National Center for Advancing Translational Sciences (NCATS) Advocacy Day on June 30, 2017, learning about their resources and programs and how they can...

Jul 07

1

NGLY1: Data as a Drug Presentation at NIH/NCATS

By NGLY1.org | NGLY1 Families, Rare Disease | One Comment

Dr. Matt Might, Chief Scientific Officer of NGLY1.org, presented at the June 28, 2017, NIH-NCATS meeting on data registries in rare disease. His presentation was entitled "NGLY1: Data as a Drug." Dr....

Blog

NGLY1.org Research update: Generation of an induced pluripotent stem cell line …

Job Opportunity: Postdoc for Innovative NGLY1 Project

Exciting News! CRADA with Retrophin, NCATS and NGLY1.org

NCATS Advocacy Day 2017

NGLY1: Data as a Drug Presentation at NIH/NCATS

Recent Posts

Recent Comments

Archives

Categories

Meta

Contact Us

Sign up for our newsletter